Cost-Effectiveness Analysis of Anastrozole versus Tamoxifen in Adjuvant Therapy for Early-Stage Breast Cancer – A Health-Economic Analysis Based on the 100-Month Analysis of the ATAC Trial and the German Health System

Publisher： Karger

E-ISSN： 2296-5262|33|4|155-166

ISSN： 2296-5270

Source： Oncology Research and Treatment, Vol.33, Iss.4, 2010-03, pp. : 155-166

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cost utility analysis of early adjuvant letrozole or anastrozole versus tamoxifen in postmenopausal women with early invasive breast cancer: the UK perspective

By Karnon Jonathan  

The European Journal of Health Economics, Vol. 9, Iss. 2, 2008-05 ,pp. : 171-183

Springer Publishing Company

Access to resources Recommend Favorite

Cost effectiveness of letrozole versus anastrozole in postmenopausal women with HR+ early-stage breast cancer

By Lipsitz Michael   Delea Thomas E.   Guo Amy  

Current Medical Research and Opinion, Vol. 26, Iss. 10, 2010-10 ,pp. : 2315-2328

Informa Healthcare

Access to resources Recommend Favorite

Breast-Conserving Therapy for Early-Stage Breast Cancer in Chinese Women: A Meta-Analysis of Case-Control Studies

By  

Oncology Research and Treatment, Vol. 35, Iss. 3, 2012-02 ,pp. : 133-139

Karger

Access to resources Recommend Favorite

Cost-Effectiveness of Hormone Replacement Therapy for Fracture Prevention in Young Postmenopausal Women: An Economic Analysis Based on a Prospective Cohort Study

By Fleurence R.   Torgerson D. J.   Reid D. M.  

Osteoporosis International, Vol. 13, Iss. 8, 2002-08 ,pp. : 637-643

Springer Publishing Company

Access to resources Recommend Favorite

Adjuvant systemic therapy for older adults with early-stage breast cancer

By Pal Sumanta Kumar   Mortimer Joanne  

Women's Health, Vol. 5, Iss. 3, 2009-05 ,pp. : 251-262

Future Medicine

Access to resources Recommend Favorite